IOO
Fibro □ Good
) ■ Intermediate
MPNST
ω
Φ
ω
ω
ф
о
о
Ф
≥
ф
ф
' Angio
й—I----)
‘ Synovial
—∣----)
Osteo
—∣----)
' MFH
«—I----)
, Lipo
H—I----)
I Leiomyo
Hj-------I------------)
’ Rhabdo
н—∣------)
Ewings
⅛—I----)
0/13
0/2
6/28
7/29
3/29
5/26
3/20
2/15
1/5
1/12
0.0 0.1 0.2 0.3 0.4 0.5
Success Rates
Figure 4.5: Central 95% credible intervals for the success rates of the treatment in the
sarcoma subtypes in the study when applying the proposed NEPPM with parameter
7 = 1. Right square bracket marks the 5% percentile. The upper two and the rest
CFs correspond, respectively, to the two and ten sarcoma subtypes with good and
intermediate prognoses.
More intriguing information
1. Pricing American-style Derivatives under the Heston Model Dynamics: A Fast Fourier Transformation in the Geske–Johnson Scheme2. STIMULATING COOPERATION AMONG FARMERS IN A POST-SOCIALIST ECONOMY: LESSONS FROM A PUBLIC-PRIVATE MARKETING PARTNERSHIP IN POLAND
3. Quality practices, priorities and performance: an international study
4. Qualification-Mismatch and Long-Term Unemployment in a Growth-Matching Model
5. The name is absent
6. The name is absent
7. European Integration: Some stylised facts
8. The name is absent
9. Insurance within the firm
10. The name is absent